✦ LIBER ✦

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

✍ Scribed by Salvador Martín-Algarra; Enrique Espinosa; Jordi Rubió; Juan José López López; José Luis Manzano; Lorenzo Alonso Carrión; Arrate Plazaola; Adnan Tanovic; Luis Paz-Ares

Book ID: 116429919
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 108 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2008.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of weekly kahalalide F as

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

✍ R. Salazar, H. Cortés-Funes, E. Casado, B. Pardo… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 209 KB

Phase II study of epirubicin in advanced

Phase II study of epirubicin in advanced malignant melanoma

✍ Massimo Lopez; Carlo-Federico Perno; Paola Papaldo; Luigi Lauro; Fabrizio Ganzin 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 194 KB

Positive phase II study in the treatment

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

✍ Karin U. Schallreuter; Eberhard Wenzel; Frank W. Brassow; Jürgen Berger; Eckard 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 331 KB

A phase II study of spirogermanium in pa

A phase II study of spirogermanium in patients with metastatic malignant melanoma

✍ Elizabeth Eisenhauer; Ian Kerr; Audley Bodurtha; Neill Iscoe; Peter McCulloch; K 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 205 KB

The National Cancer Institute of Canada Clinical Trials Group conducted a phase II study of spirogermanium given daily for 5 days every 3 weeks to previously untreated patients with malignant melanoma. In 21 evaluable patients one complete response was seen (response rate 5%). Disease progression oc

Phase II study of high-dose medroxyproge

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma

✍ Becher, R; Kloke, O; Höffken, K; Scheulen, ME; Wandl, UB; Bojar, H; Schmidt, CG 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Interferon in combination with vinblasti

Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study

✍ Stein Gundersen; A. Flokkmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol